Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1).
OBJECTIVE
To observe the effects of exercise training on plasminogen activator inhibitor, type-1 (PAI-1), tissue plasminogen activator (tPA), and associated metabolic variables in sedentary men and women.


METHODS
A randomized, controlled experimental design was used to examine the influence of 10 d of moderate-intensity exercise training on measures of fibrinolysis. Sixteen men and 16 women between the ages of 50 and 70 yr were randomly assigned to exercise (EX) and control groups (CON) that were balanced for gender and hormone replacement therapy. Blood samples were collected on days 1, 2, 11, and 12 for measurement of plasma PAI-1, tPA, insulin, glucose, and triglyceride. Subjects in EX performed 50 min of treadmill walking at an intensity corresponding to 65% of heart rate reserve each day for 10 consecutive days.


RESULTS
There were no significant changes in PAI-1, tPA, or associated metabolic variables between EX and CON during the intervention period. Within EX subjects, those with higher body fatness had a significant decrease in insulin and triglyceride compared with those with lower body fatness. However, no changes in fibrinolytic measures were observed within these subgroups.


CONCLUSIONS
Short-term exercise training does not change PAI-1 levels in normal, asymptomatic men and women. In addition, modest decreases in insulin and triglyceride in individuals with elevated body fatness do not result in changes in PAI-1 after short-term training. It appears likely that decreases in PAI-1 with exercise training require decreases in adiposity and/or marked changes in metabolic variables.
Bodary
Peter F
PF
Department of Exercise Science, School of Public Health, University of South Carolina, Columbia, SC, USA. pfbodary@umich.edu
Yasuda
Norie
N
Watson
Deidre D
DD
Brown
Adrienne S
AS
Davis
J Mark
JM
Pate
Russell R
RR
D000368:Aged; D015992:Body Mass Index; D015444:Exercise / Q000502:physiology*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009043:Motor Activity; D009765:Obesity / Q000097:blood / Q000517:prevention & control*; D015849:Plasminogen Inactivators / Q000097:blood*
D015849:Plasminogen Inactivators; D005340:Fibrinogen